Skip to main content
OpenTrials

Clinical trial condition

Select Advanced Malignancies

Explore clinical trials studying Select Advanced Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Select Advanced Malignancies trial results

Completed

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

NCT02118337

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Overland Park, Kansas, United States
  • Research Site Louisville, Kentucky, United States
View all 27 locations
View Trial Details

Related conditions